Profibrogenic Role of IL-15 Through IL-15 Receptor Alpha-mediated Trans-presentation in the Carbon Tetrachloride-induced Liver Fibrosis Model

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Jun 26

PMID 38919611

Authors

Maryse Cloutier

Bhavesh Variya

Sara Ali Akbari

Fjolla Rexhepi

Subburaj Ilangumaran

Sheela Ramanathan

Affiliations

Soon will be listed here.

Abstract

Background: Inflammatory cytokines play key pathogenic roles in liver fibrosis. IL-15 is a proinflammatory cytokine produced by myeloid cells. IL-15 promotes pathogenesis of several chronic inflammatory diseases. However, increased liver fibrosis has been reported in mice lacking IL-15 receptor alpha chain (IL-15Rα), suggesting an anti-fibrogenic role for IL-15. As myeloid cells are key players in liver fibrosis and IL-15 signaling can occur independently of IL-15Rα, we investigated the requirement of IL-15 and IL-15Rα in liver fibrosis.

Methods: We induced liver fibrosis in , and wildtype C57BL/6 mice by the administration of carbon tetrachloride (CCl). Liver fibrosis was evaluated by Sirius red and Mason's trichrome staining and α-smooth muscle acting immunostaining of myofibroblasts. Gene expression of collagens, matrix modifying enzymes, cytokines and chemokines was quantified by RT-qPCR. The phenotype and the numbers of intrahepatic lymphoid and myeloid cell subsets were evaluated by flow cytometry.

Results: Both and mice developed markedly reduced liver fibrosis compared to wildtype control mice, as revealed by reduced collagen deposition and myofibroblast content. mice showed further reduction in collagen deposition compared to mice. However, and genes were similarly induced in the fibrotic livers of wildtype, and mice, although notable variations were observed in the expression of matrix remodeling enzymes and chemokines. As expected, and mice showed markedly reduced numbers of NK cells compared to wildtype mice. They also showed markedly less staining of CD45 immune cells and CD68 macrophages, and significantly reduced inflammatory cell infiltration into the liver, with fewer pro-inflammatory and anti-inflammatory monocyte subsets compared to wildtype mice.

Conclusion: Our findings indicate that IL-15 exerts its profibrogenic role in the liver by promoting macrophage activation and that this requires trans-presentation of IL-15 by IL-15Rα.

References

Bobbala D, Chen X, Leblanc C, Mayhue M, Stankova J, Tanaka T . Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse. Diabetologia. 2012; 55(11):3010-20. DOI: 10.1007/s00125-012-2675-1. View

Koda Y, Teratani T, Chu P, Hagihara Y, Mikami Y, Harada Y . CD8 tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells. Nat Commun. 2021; 12(1):4474. PMC: 8298513. DOI: 10.1038/s41467-021-24734-0. View

Devocelle A, Lecru L, Francois H, Desterke C, Gallerne C, Eid P . Inhibition of TGF-1 Signaling by IL-15: A Novel Role for IL-15 in the Control of Renal Epithelial-Mesenchymal Transition: IL-15 Counteracts TGF-1-Induced EMT in Renal Fibrosis. Int J Cell Biol. 2019; 2019:9151394. PMC: 6642769. DOI: 10.1155/2019/9151394. View

Pellicoro A, Ramachandran P, Iredale J, Fallowfield J . Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol. 2014; 14(3):181-94. DOI: 10.1038/nri3623. View

Kautzman A, Mobulakani J, Marrero Cofino G, Quenum A, Cayarga A, Asselin C . Interleukin 15 in murine models of colitis. Anat Rec (Hoboken). 2022; 306(5):1111-1130. DOI: 10.1002/ar.25044. View

Vicari A, Schoepfer A, Meresse B, Goffin L, Leger O, Josserand S . Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis. MAbs. 2017; 9(6):927-944. PMC: 5540113. DOI: 10.1080/19420862.2017.1332553. View

Cho K, Shukla S, Kannan M, Zhang H, Amina S, Zhou S . A peptoid interleukin-15 receptor antagonist suppresses inflammation and arthritis in mice. Clin Transl Immunology. 2022; 11(11):e1432. PMC: 9686008. DOI: 10.1002/cti2.1432. View

Yokoyama S, Watanabe N, Sato N, Perera P, Filkoski L, Tanaka T . Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes. Proc Natl Acad Sci U S A. 2009; 106(37):15849-54. PMC: 2736142. DOI: 10.1073/pnas.0908834106. View

Dudek M, Pfister D, Donakonda S, Filpe P, Schneider A, Laschinger M . Auto-aggressive CXCR6 CD8 T cells cause liver immune pathology in NASH. Nature. 2021; 592(7854):444-449. DOI: 10.1038/s41586-021-03233-8. View

10.

Giannandrea M, Parks W . Diverse functions of matrix metalloproteinases during fibrosis. Dis Model Mech. 2014; 7(2):193-203. PMC: 3917240. DOI: 10.1242/dmm.012062. View

11.

Cepero-Donates Y, Rakotoarivelo V, Mayhue M, Ma A, Chen Y, Ramanathan S . Homeostasis of IL-15 dependent lymphocyte subsets in the liver. Cytokine. 2016; 82:95-101. PMC: 5293139. DOI: 10.1016/j.cyto.2015.12.012. View

12.

Rabinowitz S, Gordon S . Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli. J Exp Med. 1991; 174(4):827-36. PMC: 2118958. DOI: 10.1084/jem.174.4.827. View

13.

Villadsen L, Schuurman J, Beurskens F, Dam T, Dagnaes-Hansen F, Skov L . Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. J Clin Invest. 2003; 112(10):1571-80. PMC: 259129. DOI: 10.1172/JCI18986. View

14.

Lodolce J, Burkett P, Boone D, Chien M, Ma A . T cell-independent interleukin 15Ralpha signals are required for bystander proliferation. J Exp Med. 2001; 194(8):1187-94. PMC: 2193508. DOI: 10.1084/jem.194.8.1187. View

15.

Allard-Chamard H, Mishra H, Nandi M, Mayhue M, Menendez A, Ilangumaran S . Interleukin-15 in autoimmunity. Cytokine. 2020; 136:155258. DOI: 10.1016/j.cyto.2020.155258. View

16.

Kinoshita M, Uchida T, Sato A, Nakashima M, Nakashima H, Shono S . Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice. J Hepatol. 2010; 53(5):903-10. DOI: 10.1016/j.jhep.2010.04.037. View

17.

Mortier E, Bernard J, Plet A, Jacques Y . Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist. J Immunol. 2004; 173(3):1681-8. DOI: 10.4049/jimmunol.173.3.1681. View

18.

Gao B, Radaeva S . Natural killer and natural killer T cells in liver fibrosis. Biochim Biophys Acta. 2012; 1832(7):1061-9. PMC: 3552008. DOI: 10.1016/j.bbadis.2012.09.008. View

19.

Kandhi R, Variya B, Ramanathan S, Ilangumaran S . An improved method for isolation and flow cytometric characterization of intrahepatic leukocytes from fatty and fibrotic liver tissues. Anat Rec (Hoboken). 2022; 306(5):1011-1030. DOI: 10.1002/ar.25039. View

20.

Yu Q, Tang C, Xun S, Yajima T, Takeda K, Yoshikai Y . MyD88-dependent signaling for IL-15 production plays an important role in maintenance of CD8 alpha alpha TCR alpha beta and TCR gamma delta intestinal intraepithelial lymphocytes. J Immunol. 2006; 176(10):6180-5. DOI: 10.4049/jimmunol.176.10.6180. View